Next Article in Journal
Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions
Next Article in Special Issue
The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
Previous Article in Journal
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis
Previous Article in Special Issue
Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Review

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

1
Operating Unit Internal Medicine–Ospedale Civile di Baggiovara-AOU, 41125 Modena, Italy
2
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, 37126 Verona, Italy
3
Department of Biomedical, Metabolic and Neural Science, University of Modena and Reggio Emilia, 41125 Modena, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(11), 2841; https://doi.org/10.3390/ijms20112841
Received: 23 May 2019 / Accepted: 4 June 2019 / Published: 11 June 2019
Secondary nonalcoholic fatty liver disease (NAFLD) defines those complex pathophysiological and clinical consequences that ensue when the liver becomes an ectopic site of lipid storage owing to reasons other than its mutual association with the metabolic syndrome. Disorders affecting gonadal hormones, thyroid hormones, or growth hormones (GH) may cause secondary forms of NAFLD, which exhibit specific pathophysiologic features and, in theory, the possibility to receive an effective treatment. Here, we critically discuss epidemiological and pathophysiological features, as well as principles of diagnosis and management of some common endocrine diseases, such as polycystic ovary syndrome (PCOS), hypothyroidism, hypogonadism, and GH deficiency. Collectively, these forms of NAFLD secondary to specific endocrine derangements may be envisaged as a naturally occurring disease model of NAFLD in humans. Improved understanding of such endocrine secondary forms of NAFLD promises to disclose novel clinical associations and innovative therapeutic approaches, which may potentially be applied also to selected cases of primary NAFLD. View Full-Text
Keywords: GH deficiency; hypogonadism; hypothyroidism; PCOS GH deficiency; hypogonadism; hypothyroidism; PCOS
Show Figures

Figure 1

MDPI and ACS Style

Lonardo, A.; Mantovani, A.; Lugari, S.; Targher, G. NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. Int. J. Mol. Sci. 2019, 20, 2841. https://doi.org/10.3390/ijms20112841

AMA Style

Lonardo A, Mantovani A, Lugari S, Targher G. NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. International Journal of Molecular Sciences. 2019; 20(11):2841. https://doi.org/10.3390/ijms20112841

Chicago/Turabian Style

Lonardo, Amedeo, Alessandro Mantovani, Simonetta Lugari, and Giovanni Targher. 2019. "NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management" International Journal of Molecular Sciences 20, no. 11: 2841. https://doi.org/10.3390/ijms20112841

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop